Podcasts about vericel

Vericel acquired a hidden gem in cartilage repair that other companies had written off, and developed it into a high-growth product that could potentially address a $4 billion market. In this episode of the Vanguards of Health Care podcast, Vericel CEO Nick Colangelo sits down with Matt Henriksson, Bloomberg Intelligence analyst, to talk about how MACI took over as the market leader for cartilage repair in the knee and its potential to do so for the ankle. Colangelo also discusses why the company built a diversified portfolio and how NexoBrid complements its Epicel platform to fill out the company's burn-care offerings.See omnystudio.com/listener for privacy information.

Vericel Corporation CEO Nick Colangelo (VCEL) tells us about his company's new cell-therapy that is changing the way we treat joint injuries and restore damaged skin tissue. How telemedicine pioneer Teladoc Health (TDOC) is turning its business around… at least for the time being. Alphabet (GOOGL) shows how AI can boost a company's bottom line. Why Texas Instruments (TXN) can't seem to figure out its inventory challenges. The Drill Down with Cory Johnson offers a regular look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this series from AHLA's Early Career Professionals Council, health law professionals share their career paths, what they wish they had known as students, and what a typical day in their job looks like. In this episode, Alé Dalton, Associate, Bradley Arant Boult Cummings LLP, speaks with Masha Goodman-Khan, Director, Compliance and Legal Operations, Vericel. Masha talks about how her career trajectory led to legal compliance, how her own work brings her into contact with colleagues and departments across her company, why she pursued a Master of Jurisprudence degree over a JD, and why perfection is the enemy of good.Watch the conversation here.To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

An interview with Gerard Michel, CEO of Delcath Systems, where Gerard reflects back on his time with Vericel, the decision to become CEO of Delcath, the initial NDA submission for the HEPZATO™ KIT, and the preliminary data release from the Phase 3 FOCUS study.  Gerard also addresses the future for Delcath, including the impending full Phase 3 FOCUS results, future clinical indications to be pursued with the HEPZATO™ KIT, and commercial dynamics in the interventional oncology space.   Companies discussed during the podcast: Delcath Systems, Inc (Nasdaq: DCTH) Vericel Corporation (Nasdaq: VCEL) Immunocore Ltd (Nasdaq: IMCR) Bright Minds Biosciences (OTCQB: BMBIF, CSE: DRUG)    Gerard Michel, CEO of Delcath Systems, Inc. (“Delcath”) appeared on this episode of the podcast. Listeners are urged to review Delcath's SEC filings and cautioned not to place undue reliance on any forward-looking statements. Delcath undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws.

PitchPro is “The best of orthopedics pitched to the best in orthopedics.”  Tune in to this pitch from Vericel on MACI®. Vericel's all-star pitch team includes orthopedic surgeons, Dr. Geoffrey Van Thiel and Dr. Cassandra Lee. Listen to hear them pitch to our expert panelists, Dr. Vinod Dasa, Dr. Scott Sigman, Matthew Ray Scott and Joe Mullings. Dr. Van Thiel and Dr. Lee really nailed it with MACI's key messaging and included a few great laughs to the panelists. They took the panels heat and had seamless responses to their tough questions.  MACI is a 3rd generation ACI. For more information including Important Safety Information, please see Full Prescribing Information at MACI.com.  Want to go up against the heat of the panel on PitchPro? Email info@theorthoshow.com for more information. 

In Episode 9 of The Sports Medicine Podcast, Dr. Dold sits down with orthopedic sports medicine and cartilage specialist, Dr. Eric Strauss, MD. Dr. Strauss is a sports medicine specialist with a clinical focus on ligament reconstruction, joint preservation procedures including cartilage repair, restoration and osteotomies, meniscus surgery, and the arthroscopic treatment of orthopedic pathology affecting the knee and shoulder. He practices at NYU Langone Orthopedic Hospital in New York City and is involved with NYU's orthopedic residency program, taking on the role of program director in January 2020. As a clinician-scientist, Dr. Strauss is an active contributor to the orthopedic surgery and sports medicine literature, publishing more than 200 peer-reviewed journal articles and book chapters to help advance the field of sports medicine. His basic science and clinical research has focused extensively on the management of focal cartilage disorders around the knee, including cartilage repair and restoration, meniscus repair and transplantation, and the use of synovial fluid biomarkers to establish prognosis following intra-articular injury and prevent post-traumatic arthritis. The episode focuses primarily on the diagnosis, management, and treatment of focal cartilage lesions around the knee, including but not limited to the MACI procedure, osteochondral allografts, OATS procedure, osteotomies, and orthobiologics. For more information on Dr. Strauss, please visit: https://nyulangone.org/doctors/1508061748/eric-j-strauss https://www.sportssurgerynewyork.com/dr-eric-strauss-sports-medicine-specialist-ny.html This episode is sponsored by Vericel Corporation (www.vcel.com), the manufacturer of MACI (autologous cultured chondrocytes on porcine collagen membrane) for repair of symptomatic knee cartilage damage in adults. For more information on Vericel or MACI, please visit: www.maci.com/patients/ www.maci.com/pdf/Final-MACI-PI-FINAL.pdf www.vcel.com The Sports Medicine Podcast: Instagram: www.instagram.com/thesportsmedicinepodcast/ Email: thesportsmedicinepodcast@gmail.com Host: Dr. Andrew Dold, MD FACS FRCSC - Orthopedic Surgeon and Sports Medicine Specialist www.DoldMD.com Instagram: www.instagram.com/dr.dold.md/ www.instagram.com/thesportsmedicinepodcast/

Hoy en #ElBuscador hablamos de #VericelCorporation con @DavidGalanBolsa, director de @BolsaGeneral

Hoy en #ElBuscador hablamos de #VericelCorporation con @DavidGalanBolsa, director de @BolsaGeneral

NFL analyst and former DB Solomon Wilcots joins the show to preview the Super Bowl as well as share his thoughts on how Tony Romo has done in the booth. Nick Colangelo, the CEO of Vericel, also joined the show to talk about Maci, a knee cartilage repair.

On this week’s Tech Nation, how natural disasters shaped civilizations. Former USGS scientist, Dr. Lucy Jones joins Moira to talk about her book: “The Big Ones”. Then on Tech Nation Health, treating medical conditions with a person’s own cells. Nina Kjellson (Shell-son), Managing Partner, from Canaan Partners explains the challenges of car-T therapy in treating cancer patients, and Vericel’s Gerard Michel describes their work repairing cartilage in the knee and severe burns. Also, Chief Correspondent Dr. Daniel Kraft covers the Blue Button conference

On this week’s Tech Nation, how natural disasters shaped civilizations. Former USGS scientist, Dr. Lucy Jones joins Moira to talk about her book: “The Big Ones”. Then on Tech Nation Health, treating medical conditions with a person’s own cells. Nina Kjellson (Shell-son), Managing Partner, from Canaan Partners explains the challenges of car-T therapy in treating cancer patients, and Vericel’s Gerard Michel describes their work repairing cartilage in the knee and severe burns. Also, Chief Correspondent Dr. Daniel Kraft covers the Blue Button conference

On Tech Nation Health, treating medical conditions with a person’s own cells. Nina Kjellson (Shell-son), Managing Partner, from Canaan Partners explains the challenges of car-T therapy in treating cancer patients, and Vericel’s Gerard Michel describes their work repairing cartilage in the knee and severe burns. Also, Chief Correspondent Dr. Daniel Kraft covers the Blue Button conference

Today in FirstWord:

This week we interview Simon Vericel speaking about the right way to do PR (Public relations) in China. Simon has 10+ years of PR experience helping Chinese companies managing their PR overseas and helping foreign companies running PR campaigns is China. About Simon VericelHe is a seasoned communication strategist and team leader with a knack for business development and kick-starting things. Simon has more than 10 years experience designing highly efficient influencer and stakeholder engagement campaigns for leading Chinese brands overseas, global multinationals in China and tech startups experiencing rapid growth. He has particular focus on B2B, corporate communications, strategic positioning and messaging, media relations and crisis management across all traditional and digital platforms.Over a decade working in China has given him a unique perspective on the key factors for successful communications campaigns in the country that translate into increased awareness, reputation and sales.His industry focus covers high tech, mobile, semiconductors, IT services and software. He also have deep experience in healthcare, automotive, energy, F&B, government, finance and sports. Episode Content:Can you focus us on what you do now? what your company does?Is PR in China is different than the rest of the world?What Strategy mean in the PR world?what exactly you do to find the right strategy? Tips for startups and SMEs companies doing PR themselves in China.When is the stage for a foreign business that they would need a PR firm in China?Can they do it themselves? Is this about saving time building the connections with local websites and magazines?Should you do your PR in English, Chinese? How about both languages on the same channel? How do you do PR work, in a country where journalism is ‘censored’? Are there best practices for companies on what NOT to do when doing PR in China? Example Case studiesDo you change your PR message in the middle of a campaign?What’s the best way to reach you? Episode Mentions:MIke's new book - China Startup - Experience and Insights. A Foreigner Starting a Chinese Tech StartupShlomo’s book on LeanPub - Your Way! 6 weeks for a startup plan GMIC - Global mobile internet conferenceMegi - cloud accounting solution in ChinaQualcomm to Pay $975 Million Antitrust Fine to China Microsoft is making a custom version of Windows 10 just for ChinaChina joyWechat Sina blogsSimon's company - Influence Matters Simon's contact details - Linkedin , Simon@inmatt.comDownload and SubscribeDownload this episode: right-click on this link and choose "save as"Subscribe to China Business Cast on iTunesOr check out the full list on subscription options Periscope Live broadcasting of the recordings follow @StartupNoodle (open link on mobile)